IQVIA Holdings (IQV) has drawn fresh attention after being ranked No. 1 in its category on the 2026 Fortune World’s Most Admired Companies list for the fifth consecutive year.

At a share price of US$235.31, IQVIA’s recent recognition on the Fortune list comes as the stock shows building momentum, with a 30 day share price return of 3.7%, a 90 day share price return of 8.22%, and a 1 year total shareholder return of 15.16%.

If IQVIA’s profile has you thinking about broader healthcare opportunities, it could be a good moment to scan other healthcare stocks that might fit your watchlist next.

With IQVIA trading at US$235.31 and sitting at a 26.31% intrinsic discount with a 10.98% gap to analyst targets, the key question is whether this represents genuine value or a market already pricing in future growth.

Most Popular Narrative: 5.9% Undervalued

At a last close of $235.31 against a narrative fair value of $250.00, IQVIA is framed as modestly undervalued, with that gap hinging on specific growth and margin expectations rather than sentiment alone.

Continued investment in and deployment of proprietary platforms and agentic AI solutions, together with strategic collaborations and industry recognitions, increase switching costs and provide competitive barriers, positioning IQVIA to capture greater market share and support long-term revenue growth and margin improvement.

Curious what revenue mix, earnings trajectory, and profit margin profile need to line up for that fair value to hold? The most followed narrative ties those assumptions together, including how future earnings and valuation multiples would have to evolve to support that $250 mark.

Result: Fair Value of $250.00 (UNDERVALUED)

However, you still need to weigh risks like pricing pressure in the CRO market and IQVIA’s higher debt levels, which could challenge those upbeat earnings assumptions.

Build Your Own IQVIA Holdings Narrative

If you look at the numbers differently or prefer to test your own assumptions, you can build a full IQVIA view in just a few minutes. Do it your way

A great starting point for your IQVIA Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If IQVIA sits on your watchlist already, do not stop there. Use the Simply Wall St Screener to uncover fresh stock ideas tailored to how you like to invest.

• Spot potential income pillars by scanning these 13 dividend stocks with yields > 3% that may suit investors looking for steady cash returns.
• Explore potential growth themes by reviewing these 24 AI penny stocks that align with long term trends in automation and machine learning.
• Search for possible mispriced opportunities through these 873 undervalued stocks based on cash flows that might trade below what their cash flows suggest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.